prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |review
Now, we have set out a series of investment priorities with that kind of strategy. Like most of the NIH, our major investment is in extramural research. We�re funding 200 applications for research training and research around the United States today, as well as a few growing internationally, and these fund a whole range of approaches: Phase I to Phase III, clinical studies, pre-clinical mechanistic and translational research, as well as research training.

�We have established an intramural laboratory and clinically based research program. � It�s emphasizing clinical and translational studies of CAM approaches to age-related stressors. The frailty, the dementia, the depression, the loss of bone mass that occurs with aging. And that intramural program, as all intramural programs here, creates a nidus for research training.